ClinicalTrials HQ

hypertriglyceridemia

hypertriglyceridemia

Explore linked clinical trials. Standard reference: MONDO:0005347
View definition

46 results ยท Page 1 of 2

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic HyperlipidemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseNot yet recruitingNot applicable2026-10-09NCT07715890
Vitamin C Administration and Triglycerides Level in Critical Care PatientsDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseRecruitingNot stated2026-10-09NCT06206759
A Study of Solbinsiran (LY3561774) in Participants With Severe HypertriglyceridemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseRecruitingPhase 22026-10-08NCT07269210
Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertriglyceridemia, lipodystrophy, metabolic disease, skin disorderActive, not recruitingPhase 22026-10-08NCT02262806
Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseActive, not recruitingPhase 32026-10-01NCT06822790
A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney DiseaseDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseNot yet recruitingPhase 22026-09-30NCT07848880
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Optimizing Low-Density Lipoprotein ManagementCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, hereditary disease, hyperlipidemia, hyperlipoproteinemia, hyperlipoproteinemia type V, hypertriglyceridemia, inborn errors of metabolism, metabolic diseaseActive, not recruitingNot applicable2026-09-29NCT05088759
Standardized Large Yellow Tea Extract for Glucose and Lipid Metabolism in Overweight Adults With HypertriglyceridemiaBody Weight, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, hyperlipidemia, hypertriglyceridemia, metabolic disease, nutritional disorder, obesity disorder, overnutritionNot yet recruitingNot applicable2026-09-25NCT07840846
Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertriglyceridemia, lipodystrophy, metabolic disease, skin disorderActive, not recruitingPhase 32026-09-22NCT02262832
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute PancreatitisDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseRecruitingPhase 32026-09-21NCT06880770
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory DyslipidemiasCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, homozygous familial hypercholesterolemia, hyperlipidemia, hyperlipoproteinemia, hyperlipoproteinemia type V, hypertriglyceridemia, inborn errors of metabolism, metabolic diseaseRecruitingPhase 12026-09-18NCT07491172
Comparing Two Low-Carbohydrate Diets With a Standard Diet in Type 2 DiabetesBody Weight, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertriglyceridemia, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitusNot yet recruitingNot applicable2026-09-08NCT07801378
A Study to Assess the Safety, Tolerability and Efficacy of ION775Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseRecruitingPhase 22026-09-03NCT07604974
Study of MAR001 in Adults With Elevated Triglycerides and Remnant CholesterolDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseRecruitingPhase 22026-09-02NCT07028749
RBD5044 in Chinese Participants With HypertriglyceridemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseActive, not recruitingPhase 22026-08-24NCT07587788
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTArterial Occlusive Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hyperlipidemia, hypertriglyceridemia, metabolic disease, myocardial ischemia, vascular disorderNot yet recruitingPhase 42026-08-13NCT07762755
Pemafibrate for Symptomatic ICAS RCTDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hyperlipidemia, hypertriglyceridemia, metabolic disease, nervous system disorder, stroke disorder, vascular disorderRecruitingNot applicable2026-08-03NCT07562178
Culturally Adapted Dietary Clinical Trial in PRBody Weight, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Obesity, Abdominal, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperglycemia, hyperlipidemia, hypertensive disorder, hypertriglyceridemia, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, vascular disorderRecruitingNot applicable2026-07-28NCT05962372
Cardiovascular-Kidney-Metabolic Syndrome RegistryBody Weight, Chronic Disease, Disease Attributes, Dyslipidemias, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, cardiovascular disorder, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, hypertensive disorder, hypertriglyceridemia, kidney disorder, kidney failure, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus, urinary system disorder, vascular disorderNot yet recruitingNot stated2026-07-22NCT07718789
Phase 1b Study of VERVE-201 in Patients With Refractory HyperlipidemiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, familial hypercholesterolemia, hereditary disease, hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, inborn errors of metabolism, metabolic diseaseRecruitingPhase 12026-07-17NCT06451770
A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaDigestive System Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, fatty liver disease, hyperlipidemia, hypertriglyceridemia, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, pancreas disorder, pancreatitisNot yet recruitingPhase 32026-07-10NCT07693777
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe HypertriglyceridemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseNot yet recruitingPhase 32026-07-06NCT07680829
CS-121 APOC3 Base Editing in Severe HypertriglyceridemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseNot yet recruitingEarly phase 12026-06-18NCT07657780
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic PlaqueDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseEnrolling by invitationNot applicable2026-06-17NCT07050134
A Study of SHR-1918 In Participants With HypertriglyceridemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic diseaseRecruitingPhase 32026-06-16NCT07349615